IBIO

iBio (IBIO)

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:AMEX:IBIO
DataOraFonteTitoloSimboloCompagnia
27/03/202412:00GlobeNewswire Inc.iBio and AstralBio Announce Transformative AI drug discovery Collaboration to Rapidly Develop Novel Antibodies for Obesity and Cardiometabolic DiseasesAMEX:IBIOiBio Inc
27/03/202400:35GlobeNewswire Inc.iBio Announces $15.0 Million Private PlacementAMEX:IBIOiBio Inc
26/02/202413:59Edgar (US Regulatory)Form 8-K - Current reportAMEX:IBIOiBio Inc
26/02/202413:45GlobeNewswire Inc.iBio Announces Sale of Preclinical PD-1 Agonist Antibody Program to OtsukaAMEX:IBIOiBio Inc
16/01/202414:15GlobeNewswire Inc.iBio Announces Participation in 23rd Annual PepTalk ConferenceAMEX:IBIOiBio Inc
10/01/202419:24Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansAMEX:IBIOiBio Inc
04/01/202414:00Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsAMEX:IBIOiBio Inc
26/12/202313:15GlobeNewswire Inc.iBio Amends and Extends Maturity of Credit AgreementAMEX:IBIOiBio Inc
06/12/202314:59Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]AMEX:IBIOiBio Inc
05/12/202314:00GlobeNewswire Inc.iBio, Inc. Announces Pricing of $4.5 Million Public OfferingAMEX:IBIOiBio Inc
05/12/202306:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessAMEX:IBIOiBio Inc
30/11/202314:55Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]AMEX:IBIOiBio Inc
27/11/202323:20GlobeNewswire Inc.iBio Announces Reverse Stock SplitAMEX:IBIOiBio Inc
03/11/202321:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:IBIOiBio Inc
01/11/202313:24GlobeNewswire Inc.iBio Further Expands Tech Stack with ShieldTx™; Enhances Immuno-Oncology Development Pipeline with Conditionally Activated MUC16xCD3 BispecificAMEX:IBIOiBio Inc
27/10/202322:29Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933AMEX:IBIOiBio Inc
26/10/202314:22Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersAMEX:IBIOiBio Inc
26/10/202314:20Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsAMEX:IBIOiBio Inc
16/10/202322:59Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsAMEX:IBIOiBio Inc
10/10/202314:00GlobeNewswire Inc.iBio to Highlight Technology for Advancing Discovery of Bispecifics at Festival of BiologicsAMEX:IBIOiBio Inc
02/10/202312:45GlobeNewswire Inc.iBio Explains Recent Filing of Registration StatementAMEX:IBIOiBio Inc
29/09/202323:28Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementAMEX:IBIOiBio Inc
27/09/202322:19GlobeNewswire Inc.iBio Announces Filing of 2023 Annual Report on SEC Form 10-KAMEX:IBIOiBio Inc
27/09/202322:01Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]AMEX:IBIOiBio Inc
21/09/202322:05GlobeNewswire Inc.iBio Announces Amendment to Credit Agreement with WoodforestAMEX:IBIOiBio Inc
15/08/202322:02Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesAMEX:IBIOiBio Inc
14/08/202322:15GlobeNewswire Inc.iBio Reports Triple Milestone: In Vivo Proof-of-Concept for Three Programs, a Transformative Step in Advancing its Immuno-Oncology Pre-Clinical Pipeline Towards Clinical DevelopmentAMEX:IBIOiBio Inc
07/08/202315:29Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]AMEX:IBIOiBio Inc
27/06/202314:12Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:IBIOiBio Inc
27/06/202314:01Edgar (US Regulatory)Current Report Filing (8-k)AMEX:IBIOiBio Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:AMEX:IBIO
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network